Cobenfy, a schizophrenia drug, shows promise in treating Alzheimer’s disease.
Bristol Myers Squibb Believes Alzheimer’s is Largest Market for Schizophrenia Drug Cobenfy Bristol Myers Squibb believes that Alzheimer’s disease is the largest…
Bristol Myers Squibb Believes Alzheimer’s is Largest Market for Schizophrenia Drug Cobenfy Bristol Myers Squibb believes that Alzheimer’s disease is the largest…
Author and Psychologist Dr. Jordan Peterson Analyzes “Daniel Penny Effect” Dr. Jordan Peterson, an author and psychologist, recently analyzed the influence of…
Researchers Find Taking More Steps Each Day Can Lead to Reduced Depression Symptoms A recent study published in the journal JAMA Network…